The proteasome-regulating kinase DYRK2 as a target in breast cancer and multiple myeloma

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer; multiple myeloma (MM)

Inhibiting the proteasome-regulating kinase DYRK2 could treat breast cancer and MM. In patients with

Read the full 216 word article

User Sign In